• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® ACUSEAL VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® ACUSEAL VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER Back to Search Results
Catalog Number ECH060040W
Device Problem Peeled/Delaminated (1454)
Patient Problem Vascular Dissection (3160)
Event Date 10/08/2021
Event Type  Injury  
Manufacturer Narrative
Patient weight information was not made available.Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
The following was reported to gore: on (b)(6) 2021, a patient was implanted with a gore® acuseal vascular graft during a arteriovenous graft (avg) procedure.The graft anastomosis was brachial artery and median cubital vein.During the postoperative follow-up on (b)(6) 2021, it was found there was dissection at anastomotic site of graft in the area of arteriovenous puncture and vein segment passing through the elbow joint, which led to thrombosis.It was also found vcuseal vascular graft silica gel layer delamination at same area.Physician suspected that the dissection/thrombosis/device delamination might be caused by two issues, one was that the tunneler (u type) used during initial procedure was not appropriate, the other was that the puncture operation may hurt vascular graft during hemodialysis as the patient had kidney disease.The vcuseal vascular graft was removed and another non-gore vascular graft (maquet) was used to complete the procedure on (b)(6) 2021.The patient tolerated procedure.
 
Manufacturer Narrative
A review of the manufacturing records, indicated the lots met all pre-release specifications.Due to no device and no imaging return, an evaluation could not be performed.
 
Manufacturer Narrative
H6: add component code.B5: describe event or problem - correction of the wording from "vcuseal" to "acuseal".
 
Event Description
The following was reported to gore: on (b)(6) 2021, a patient was implanted with a gore® acuseal vascular graft during a arteriovenous graft (avg) procedure.The graft anastomosis was brachial artery and median cubital vein.During the postoperative follow-up on (b)(6) 2021, it was found there was dissection at anastomotic site of graft in the area of arteriovenous puncture and vein segment passing through the elbow joint, which led to thrombosis.It was also found acuseal vascular graft silica gel layer delamination at same area.Physician suspected that the dissection/thrombosis/device delamination might be caused by two issues, one was that the tunneler (u type) used during initial procedure was not appropriate, the other was that the puncture operation may hurt vascular graft during hemodialysis as the patient had kidney disease.The acuseal vascular graft was removed and another non-gore vascular graft (maquet) was used to complete the procedure on (b)(6) 2021.The patient tolerated procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® ACUSEAL VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
qiong wang
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key12695048
MDR Text Key278824439
Report Number2017233-2021-02489
Device Sequence Number1
Product Code DSY
Combination Product (y/n)Y
Reporter Country CodeCH
PMA/PMN Number
K130215
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 12/13/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/30/2023
Device Catalogue NumberECH060040W
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/14/2021
Initial Date FDA Received10/26/2021
Supplement Dates Manufacturer Received10/14/2021
10/14/2021
Supplement Dates FDA Received11/24/2021
12/13/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/30/2020
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age59 YR
Patient SexMale
-
-